Echo Therapeutics Inc (ECTE) – A Stock With No Revenue And A Short CatalystGuest Post
Platinum Partners is the largest investor in Echo Therapeutics (common, warrants, pref and debt). Below is the author's take on the stock itself, but it raises some bigger questions regarding Platinum such as:
- why was platinum (a $1 billion fund) repeatedly investing in such a micro cap stock.
- How did Platinum value its investment in the warrants and preferred as there is no “market” for these illiquid investments. As you know there were some questions about how Platinum valued some of its other investments . . .
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email firstname.lastname@example.org and we will get back to you as quick as humanly possible